Related Experiment Video

Updated: Jul 13, 2026

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells
10:21

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells

Published on: February 21, 2018

Adaptor protein Lnk negatively regulates the mutant MPL, MPLW515L associated with myeloproliferative disorders

Sigal Gery1, Saskia Gueller, Katya Chumakova

  • 1Division of Hematology/Oncology, UCLA School of Medicine, Cedars-Sinai Medical Center, 8700 Beverly Boulevard, Los Angeles, CA 90048, USA. gerys@cshs.org

Blood
|August 19, 2007
PubMed

Insights

The adaptor protein Lnk inhibits cytokine-independent growth in myeloproliferative disorder (MPD) cells with activating MPLW515L mutations. Lnk negatively regulates MPL signaling, offering potential therapeutic strategies for MPD.

Area of Science:

  • Hematology
  • Molecular Biology
  • Oncology

Background:

  • Activating mutations in the myeloproliferative leukemia virus oncogene (MPL), specifically MPLW515L/K, are implicated in myeloproliferative disorders (MPDs).
  • MPLW515L mutations drive cytokine-independent proliferation of hematopoietic cells by activating downstream signaling pathways.
  • The adaptor protein Lnk functions as a negative regulator for several cytokine receptors, including MPL.

Purpose of the Study:

  • To investigate the role of the adaptor protein Lnk in regulating hematopoietic cell proliferation driven by MPLW515L mutations.
  • To elucidate the molecular mechanisms by which Lnk modulates MPL signaling pathways in the context of MPD.

Main Methods:

  • Overexpression and suppression of Lnk in Ba/F3-MPLW515L and UT7-MPLW515L cell lines, respectively.
  • Analysis of downstream signaling pathway activation (Jak2, Stat3, Erk, Akt).
  • Assessment of Lnk association with MPL receptors and its dependence on the Lnk SH2 domain.

Main Results:

  • Overexpression of Lnk inhibited cytokine-independent growth of Ba/F3-MPLW515L cells, while Lnk suppression enhanced proliferation in UT7-MPLW515L cells.
  • Lnk effectively blocked the activation of key signaling molecules including Jak2, Stat3, Erk, and Akt.
  • MPLW515L-expressing cells demonstrated increased susceptibility to Lnk's inhibitory effects compared to MPL wild-type cells.
  • Lnk was found to associate with and colocalize with both activated MPLWT and MPLW515L at the plasma membrane, with the SH2 domain being critical for this interaction and subsequent downregulation.

Conclusions:

  • Lnk acts as a crucial negative regulator of MPLW515L signaling, inhibiting cytokine-independent proliferation in hematopoietic cells.
  • The findings highlight the essential role of the Lnk SH2 domain in mediating the inhibitory function of Lnk on MPL signaling.
  • Understanding Lnk's regulatory mechanisms in MPLW515L signaling provides insights into MPD pathogenesis and potential therapeutic targets.

More Related Videos

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

Transduction-Transplantation Mouse Model of Myeloproliferative Neoplasm08:12

Transduction-Transplantation Mouse Model of Myeloproliferative Neoplasm

Published on: December 22, 2016

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Cytoskeletal Linker Proteins - Plakins01:09

Cytoskeletal Linker Proteins - Plakins

Plakins are large proteins with binding domains for microtubules, microfilaments, intermediate filaments, and membrane-associated protein complexes at cell junctions. Plakin functions are evolutionarily conserved and are primarily involved in organizing the different components of the cytoskeleton by crosslinking them to each other and connecting them to the cell-matrix and cell adhesion complexes. They are also known to interact with signal transducers, serve as scaffolds for signaling...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.